Skip to content

Circles

V

Veraxa Biotech AG - Post de-SPAC

VRXAW· Nasdaq

VRXAW · Veraxa Biotech AG - Post de-SPAC · Thaler

V

Veraxa Biotech AG - Post de-SPAC

VRXAW· Nasdaqneeds manual mappingCIK 2079109

FollowFollowingStance

Pharmaceutical preparations566 peers

Last sale: Oct 2, 2026 · -29.40%
Market cap: —; no share count on file
Filings: 53

Price

$0.0353

Oct 2, 2026 · IEX last sale

Range

$0.05$0.10$0.20$0.50$1.00

Jun 2026Jun 2026Jun 2026Jul 2026Aug 2026Oct 2026

IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

No financial figures on file for VRXAW yet.

Segments

Your note

Ask about the filings

Insider activity

Veraxa Biotech AG - Post de-SPAC · CIK 2079109 · Engraved from SEC EDGAR

Holders

Latest

Sep 14 · Initial ownership3

Sep 4 · Prospectus supplement424B3

Sep 4 · Prospectus supplement424B3

Sep 4 · Foreign issuer report6-K

Aug 31 · Insider filing4

Filings

3

Sep 14, 20260001829126-26-010085

424B3

Sep 4, 20260001829126-26-009754

424B3

Sep 4, 20260001829126-26-009753

6-K

Sep 4, 20260001829126-26-009752

4

Aug 31, 20260001829126-26-009544

4

Aug 31, 20260001829126-26-009543

6-K

Aug 24, 20260001829126-26-009237

3

Aug 20, 20260001829126-26-009154

SCHEDULE 13G/A

Aug 13, 20260001167557-26-000206

424B5

Aug 10, 20260001829126-26-008548

424B5

Aug 10, 20260001829126-26-008547

EFFECT

Aug 6, 20269999999995-26-002591

EFFECT

Aug 6, 20269999999995-26-002577

F-1/A

Aug 5, 20260001829126-26-008400

+ 39 more on file

Latest filing Sep 14, 2026

Raw coverage

NetFeeAmt2

TtlFeeAmt2

TtlOfferingAmt2

TtlOffsetAmt2

TtlPrevslyPdAmt2

The ffd concepts with the most facts on file for this company.

Provenance

Peers

Compare with the largest 5

Pharmaceutical preparations

566 covered companies are filed under this code. SIC 2834

CompanyRevenueGrowthNet marginMarket cap

JNJJohnson & Johnson$94.2B6.0%28.5%$617.0B E

LLYELI LILLY & Co$65.2B44.7%31.7%$1.1T M

MRKMerck & Co., Inc.$65.0B1.3%28.1%$356.0B P

PFEPfizer Inc$62.6B1.6%12.4%$158.5B A

ABBVAbbVie Inc.$61.2B8.6%6.9%$464.6B A

AZNAstraZeneca PLC$58.7B8.6%17.4%—B

BMYBristol Myers Squibb Co$48.2B0.2%14.6%$124.9B A

ABTAbbott Laboratories$44.3B5.7%14.7%$168.7B

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, largest by revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Circles Account Terms Privacy

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

ProvenanceData status and checks

Holders

UBS Group AG157.2K · —Geode Capital Management, LLC119.8K · —CSS LLC1.6M · —LMR Partners LLP1.1M · —

30 managers · Quarter ended Jun 30, 2026All holders ›

—

Insider activity

Open insider activity

Baumann Oliver RolfPurchase · 50,000 · Aug 27, 2026 Antz Christoph RudigerPurchase · 5,000 · Aug 27, 2026

2 transactions